3 active not recruiting, 2 unknown, 1 completed, 1 not yet recruiting. 4 Phase 2, 2 Phase 1, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 2, Not yet recruiting 1, Unknown 1 |
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Mucinous Adenocarcinoma: new trials by email Literature Review of Mucinous Adenocarcinoma trials Research Report on Mucinous Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer Samuraciclib + Gemcitabine & Nab-Paclitaxel - Pancreas Ductal Adenocarcinoma, Pancreas Cancer, Metastatic | Phase 1 / Phase 2 | Not yet recruiting | University Health Network, Toronto | 67 | 2026-07-01 | 2026-06-24 |
| Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors FAPI PET/CT - Renal Cell Carcinoma, Gastric Cancer | Not applicable | Unknown | Guangdong Provincial People's Hospital | 30 | 2024-01-11 | 2024-01-22 |
| METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin Nivolumab, Oxaliplatin - Colorectal Adenocarcinoma, Mucinous Adenocarcinoma | Phase 2 | Active not recruiting | University Hospital, Akershus | 80 | 2022-10-05 | 2026-01-07 |
| BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei Bromelain, Acetylcysteine, Interventional radiology insertion of drain - Pseudomyxoma Peritonei, Peritoneal Cancer | Phase 2 | Unknown | Mucpharm Pty Ltd | 62 | 2022-05-01 | 2022-03-15 |
| Phase I Trial HIPEC With Nal-irinotecan nanoliposomal irinotecan - Peritoneal Cancer, Pseudomyxoma Peritonei | Phase 1 | Completed | Stony Brook University | 18 | 2019-10-22 | 2022-05-06 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Biospecimen Collection, Computed Tomography, Echocardiography Test - Acinar Cell Carcinoma, Adenoid Cystic Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 798 | 2017-01-30 | 2026-06-17 |
| Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Bevacizumab, Carboplatin, Docetaxel - Clear Cell Adenocarcinoma, Fallopian Tube Clear Cell Adenocarcinoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 1052 | 2007-12-06 | 2025-12-30 |
Adenocarcinoma, Mucinous (7) · Pseudomyxoma Peritonei (3) · Carcinoma, Signet Ring Cell (2) · Colorectal Neoplasms (2) · Neoplasms, Cystic, Mucinous, and Serous (2) · Stomach Neoplasms (2) · Adenocarcinoma, Bronchiolo-Alveolar (1) · Adenocarcinoma, Clear Cell (1) · Adrenocortical Carcinoma (1) · Bile Duct Neoplasms (1) · Brenner Tumor (1) · Carcinoma (1) · Carcinoma, Acinar Cell (1) · Carcinoma, Adenoid Cystic (1) · Carcinoma, Basal Cell (1)
Adenocarcinoma (7) · Neoplasms (7) · Neoplasms by Histologic Type (7) · Neoplasms, Glandular and Epithelial (7) · Carcinoma (6) · Neoplasms by Site (5) · Neoplasms, Cystic, Mucinous, and Serous (5) · Digestive System Diseases (4) · Digestive System Neoplasms (4) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3)
Gemcitabine (2) · Nivolumab (2) · 130-nm albumin-bound paclitaxel (1) · Acetylcysteine (1) · Bevacizumab (1) · Bromelains (1) · CTLA-4 Antigen (1) · Carboplatin (1) · Disulfides (1) · Docetaxel (1) · Fluorouracil (1) · Immunoglobulin G (1) · Ipilimumab (1) · Leucovorin (1) · Magnetic Resonance Spectroscopy (1)
National Cancer Institute (NCI) (2) · Guangdong Provincial People's Hospital (1) · Mucpharm Pty Ltd (1) · Stony Brook University (1) · University Health Network, Toronto (1) · University Hospital, Akershus (1)
United States (3) · Canada (1) · China (1) · Guam (1) · Japan (1) · Norway (1) · South Korea (1)
Alvaro Arjona Sanchez, MD (1) · Armando Sardi, MD (1) · Christian Kersten, MD, PhD (1) · Edward Levine, MD (1) · Georgios Georgakis, MD (1) · Haroon Choudry, MD (1) · Ignace de Hingh, MD (1) · Joseph Kim, MD (1) · Minsig Choi, MD (1) · Robert L Coleman (1) · Sandip P Patel (1)
PMID 28438473, PMID 31722153, PMID 31969335, PMID 33362722, PMID 33882143, PMID 34380663, PMID 34716198, PMID 36410913, PMID 37185961, PMID 38243705, PMID 38358334, PMID 39067873, PMID 39343510, PMID 39417692, PMID 39583952, PMID 39856213, PMID 40402690, PMID 40588371, PMID 41672597, PMID 41892875, PMID 41995270, PMID 42499790
2019 (1), U10CA027469 (1), U10CA180868 (1), U10CA180888 (1)